Literature DB >> 23641449

Health screening of newly resettled refugees in a primary care setting.

Sylvia Lacourse1, Natasha Rybak, Carol Lewis, Jennifer Gartman, Jerome Larkin, Suzanne McLaughlin, Elizabeth T Toll.   

Abstract

Since October 2008, the Medicine/Pediatrics Primary Care Center (MPPCC) has been working with Rhode Island's refugee resettlement agency to coordinate medial care for newly resettled adults and adolescent refugees. The process includes obtaining extensive screening labs and providing immunizations. This review discusses the results of selected screening tests for latent TB, stool parasites, vitamin D, and vaccine-preventable diseases, such as hepatitis, performed as part of the initial intake exam during the first two years of operation of the MPPCC Refugee Clinic.

Entities:  

Keywords:  Medicine/ Pediatrics Primary Care Center; Refugee clinic; TB; hepatitis

Mesh:

Year:  2013        PMID: 23641449      PMCID: PMC5523936     

Source DB:  PubMed          Journal:  R I Med J (2013)        ISSN: 0363-7913


  14 in total

1.  Immunization status of refugee children after resettlement.

Authors:  Delma-Jean Watts; Jennifer F Friedman; Patrick M Vivier; Christine E A Tompkins; Andanthon J Alario
Journal:  Med Health R I       Date:  2011-10

2.  Susceptibility to measles, mumps, and rubella in newly arrived adult immigrants and refugees.

Authors:  Christina Greenaway; Pierre Dongier; Jean-François Boivin; Bruce Tapiero; Mark Miller; Kevin Schwartzman
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

3.  Hepatitis B virus infection among refugees resettled in the U.S.: high prevalence and challenges in access to health care.

Authors:  Oidda Ikumboka Museru; Monica Vargas; Mary Kinyua; Kelly T Alexander; Carlos Franco-Paredes; Alawode Oladele
Journal:  J Immigr Minor Health       Date:  2010-12

4.  Prevalence of tuberculosis, hepatitis B virus, and intestinal parasitic infections among refugees to Minnesota.

Authors:  Alan R Lifson; Dzung Thai; Ann O'Fallon; Wendy A Mills; Kaying Hang
Journal:  Public Health Rep       Date:  2002 Jan-Feb       Impact factor: 2.792

5.  Vitamin D deficiency among newly resettled refugees in Massachusetts.

Authors:  Katherine Penrose; Jo Hunter Adams; Thinh Nguyen; Jennifer Cochran; Paul L Geltman
Journal:  J Immigr Minor Health       Date:  2012-12

6.  Albendazole therapy and enteric parasites in United States-bound refugees.

Authors:  Stephen J Swanson; Christina R Phares; Blain Mamo; Kirk E Smith; Martin S Cetron; William M Stauffer
Journal:  N Engl J Med       Date:  2012-04-19       Impact factor: 91.245

7.  Seroprevalence of measles, rubella, and varicella in refugees.

Authors:  Elizabeth D Barnett; Demian Christiansen; Marisol Figueira
Journal:  Clin Infect Dis       Date:  2002-07-24       Impact factor: 9.079

8.  Infectious disease screening for refugees resettled in the United States.

Authors:  Elizabeth D Barnett
Journal:  Clin Infect Dis       Date:  2004-08-27       Impact factor: 9.079

9.  Vitamin D deficiency in a multinational refugee population.

Authors:  H D Wishart; A M F Reeve; C C Grant
Journal:  Intern Med J       Date:  2007-05-21       Impact factor: 2.048

10.  Health care utilization of refugee children after resettlement.

Authors:  Delma-Jean Watts; Jennifer F Friedman; Patrick M Vivier; Christine E A Tompkins; Anthony J Alario
Journal:  J Immigr Minor Health       Date:  2012-08
View more
  2 in total

1.  Phylogenetic and geospatial evaluation of HIV-1 subtype diversity at the largest HIV center in Rhode Island.

Authors:  Philip A Chan; Marissa B Reitsma; Allison DeLong; Bruce Boucek; Amy Nunn; Marco Salemi; Rami Kantor
Journal:  Infect Genet Evol       Date:  2014-04-08       Impact factor: 3.342

2.  Improving screening and management of latent tuberculosis infection: development and evaluation of latent tuberculosis infection primary care model.

Authors:  Marina Kunin; Mark Timlin; Chris Lemoh; David A Sheffield; Alana Russo; Shegofa Hazara; Jacqueline McBride
Journal:  BMC Infect Dis       Date:  2022-01-12       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.